Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis
Authors
Keywords
Calreticulin, Janus Kinase 2, Primary fibrosis, Splenomegaly, Thrombosis, Meta-analysis
Journal
ANNALS OF HEMATOLOGY
Volume 95, Issue 9, Pages 1391-1398
Publisher
Springer Nature
Online
2016-07-04
DOI
10.1007/s00277-016-2712-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms
- (2015) Seon Young Kim et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations
- (2015) C. Al Assaf et al. HAEMATOLOGICA
- Calreticulin mutation profile in Indian patients with primary myelofibrosis
- (2015) Sudha Sazawal et al. Hematology
- JAK2V617F,MPL, andCALRMutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis
- (2015) Bo Hyun Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
- (2015) P Guglielmelli et al. Blood Cancer Journal
- Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations
- (2015) C. Al Assaf et al. HAEMATOLOGICA
- CALRmutations in myeloproliferative neoplasms: Hidden behind the reticulum
- (2014) Paola Guglielmelli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management
- (2014) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients
- (2014) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
- (2014) E. Rumi et al. BLOOD
- The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants
- (2014) A. Tefferi et al. BLOOD
- Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
- (2014) A. Tefferi et al. BLOOD
- Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients
- (2014) C. Qiao et al. HAEMATOLOGICA
- JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
- (2014) S. Shirane et al. HAEMATOLOGICA
- Calreticulin mutations in Chinese with primary myelofibrosis
- (2014) B. Li et al. HAEMATOLOGICA
- Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations
- (2014) H. Andrikovics et al. HAEMATOLOGICA
- A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia
- (2014) Yining Yang et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
- (2014) A Tefferi et al. LEUKEMIA
- Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment
- (2014) R Fu et al. LEUKEMIA
- The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
- (2014) P Guglielmelli et al. LEUKEMIA
- Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
- (2014) A Tefferi et al. LEUKEMIA
- CALRandASXL1mutation analysis in 190 patients with essential thrombocythemia
- (2014) Hongjie Shen et al. LEUKEMIA & LYMPHOMA
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Mutations and prognosis in primary myelofibrosis
- (2013) A M Vannucchi et al. LEUKEMIA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline for the diagnosis and management of myelofibrosis
- (2012) John T. Reilly et al. BRITISH JOURNAL OF HAEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now